peds Flashcards

(55 cards)

1
Q

risk factors for otitis media

A

smoke exposure
formula feeding
immunization status
atopy
daycare attendance
males
family history
onset before 12 months
non white
congenital anomalies
immune deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

difference in anatomy with kids in ears

A

shorter eustachian tube

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

bacteria is isolated from what percent of acute otitis media

A

65-75%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

commom pathogens for acute otitis media

A

strep pneumo
h. flu
moraxella cat

  • strep pyogenes (rare)
  • viral 30%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

when is pneumococcal vax given

A

2,4,6,12-15 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does tympanic membrane look in AOM

A

bulging
cloudy or purulent
immobile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

diagnosis of acute otitis media requires what

A
  1. acute onset
  2. middle ear effusion
  3. symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

severe otitis media classification

A

> 39

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

patient populations that have the option to observe and not treat

A

nonsevere unilateral 6 month-2 years
nonsevere unilateral and bilateral 2 years +

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

if we choose to observe how long do we observe

A

48-72 hours
follow-up if failure
SNAP - safety net prescription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how is strep pneumo overcome in treatment of AOM

A

high dose amoxicillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how is h flu and moraxella over come in treatment of AOM

A

amox/clav
adding a beta lactamase inhib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

first line treatment AOM

A

amoxicillin 80-90mg/kg/day q12 h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

when do we not use amoxicillin first line in AOM

A

allergy
known resistance
treatment failure (after 72h)
amoxicillin in last 30 days
conjuncitvitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

2nd line therapy used if amoxicillin failure or if high dose amoxicillin in last 30 days or conjuctivitis

A

amoxicillin/clav 90 mg/kg q12h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

clav consideration

A

keep at <10 mg/kg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

amox/clav strength

A

600/42.9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

2nd line if pt has amox allergy

A

cefpodoxime
cefuroxime
cefdinir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

when would we use ceftriaxone

A

oral not available
treatment failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ceftraixone dosage form and dosing

A

IM
1 injection if initial dose
3 injections if treatment failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

disadvantages of ceftriaxone

A

calcium coadmin
c. diff risk
avoid in <1 month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

how long should we have AOM treatment in < 2 years old pts

A

10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

for pts over 2 years how long to treat

A

5-7 days
10 days if:
- severe or recurrent
- TM perforation

24
Q

adjunctive therapy for AOM

A

APAP 10-15 mg/kg/day
ibuprofen 5-10 mg/kg/day
- ibuprofen not for <6 months

25
lidocaine OTC drop usage
do not use in ruptured membrane or tubes may consider in 2+
26
follow-up timeline AOM
young infants -days young children w freq - 2 weeks children w sporadic episode - 1 month older children - not needed
27
who may benefit from antibiotic prophylaxis AOM
> 6 episodes per year
28
treatment of AOM in tubes pts
ofloxacin or levofloxacin drops 4-5 drops BID 5-7 days
29
chronic supperative ottiis media risk pathogen
MRSA (lasting >6 weeks)
30
chronic supperative otitis media treatmetn
ofloxacin or cipro drops x 2 weeks
31
otitis externa (swimmers ear) orgnaisms
pseudomonas staph aureus fungal
32
otitis externa swimmers ear treatmet
ear drops
33
UTI ped risk factors girls
white <12 months temp >39 fever > 2 days
34
UTI ped risk factors boys
non black temp >39 fever >24 h uncircumcised
35
pathogens causing UTI in kids
e. coli 80-85% also Klebsiella
36
signs and symptoms of UTI in peds
check all fever children < 2 years newborns - jaundice, looking sick infants/young kids - flank pain, foul urine school kids - dysuria, frequnecy, urgency
37
preferred method of urine collection peds
catheterization fo < 2 years old
38
positive urinalysis results indicating UTI in ped
leukocyte esterase nitrite
39
urine culture that would not be contaminanted CFU cound
> 100,000 > 10,000 in catheter
40
treatment of UTI in children
cephalexin q 6 hours could do Bactrim last line is FQs
41
what can we not give in a feeding tube
fluroquinolones
42
duration of treatment of UTI in uncomplicated < 2 years
7 days
43
duration of treatment of UTI in pyelonephritis peds
10-14 days
44
duration of treatment in UTI of older female peds
3-7 days
45
IV vs oral for UTI
IV if cant keep oral down (ceftriaxone) or if looking toxic
46
what is bronchiolitis
lower resp infection viral edema, inflammation
47
what causes bronchiolitis
RSV rhinovirus
48
RSV season is when
November-April
49
risk factors for RSV
age < 6 months pre-term chronic lung disease weakened immune system
50
treatment of bronchiolitis
supportive therapy! - oxygen - hydration - mechanical vent - ECMO
51
how can we prevent RSV
nirsevimab pregnant people vaccine
52
vaccine for pregnant people RSV
Abrysvo
53
how much time before pregnancy must RSV vaccine be given to pregnant women
14 days before delivery
54
when can babies get Nirsevimab
right at birth if RSV season right before RSV season in office if its not in season
55
who should get second nirsevimab dose
chronic lung disease chronic corticosteroid therapy immunocompromised heart disease Indian